Topic: Food and Drug Administration

IPXL) confirmed Friday that Abbott Laboratories (ABT) and an Abbott subsidiary filed suit against the company for patent infringement, in connection with a generic version of Simcor extended-release tablets, a drug used to reduce elevated cholesterol levels.. California-based Impax said it filed ...

New drugs are developed every day through pharmaceutical companies. New drugs can take around 15 years before a single pill makes it to marketing, so the estimated costs of getting the medication ready add up.. Add in extra study costs. Costs of ...

The FDA will take an extra three months to review Merck KGaA's oral multiple sclerosis pill cladribine after granting the therapy priority review last summer, the WSJ reports. This fall, a European regulatory advisory panel recommended against the drug's approval, raising doubts ...

The U.K. Food Standards Agency (FSA) which advises the government on food safety issues, said Thursday November 25 that tests have been carried out on meat and milk from cloned cattle and findings are that the products are safe for consumption. There ...

Eli Lilly and Company (LLY) and partner Acrux recently announced good news in the form of US Food and Drug Administration (FDA) approval for Axiron. Per the terms of the deal, Eli Lilly made an upfront payment of $50 million and $3 ...

Nov. 23--CNS Therapeutics, which likely is the only pharmaceutical company based in the city of St. Paul, said Monday it has received approval from the U.S. Food and Drug Administration to sell its first product.. Called Gablofen, the drug is approved for ...

In 1837, Hans Christian Andersen authored a short tale titled The Emperor's New Clothes. Despite ample evidence that pan-PI3K inhibitors and dual PI3K/mTOR inhibitors might offer a therapeutic advantage, tailors continue to weave new compounds targeting individual components of the pathway with ...

FDA says maker of Darvon painkiller will withdrawal drug after evidence of deadly heart risksThe maker of the painkiller Darvon is pulling the drug off the market under pressure from public health officials who say it causes dangerous heart rhythms.The Food and ...

FDA expands approval of Amgen bone-strengthening drug to cancer patients with solid tumorsBiotech drugmaker Amgen says federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in patients with advanced cancer.The Food and Drug Administration cleared the company's drug denosumab ...

HGSI) and GlaxoSmithKline PLC (GSK) today announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve Benlysta (belimumab) for the treatment of autoantibody-positive patients with active systemic ...